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Abstract
Ureaplasma species are the most frequently isolated microorganisms inside the amniotic cavity and have been associated
with spontaneous abortion, chorioamnionitis, premature rupture of the membranes (PROM), preterm labour (PL)
pneumonia in neonates and bronchopulmonary dysplasia in neonates. The mechanisms by which Ureaplasmas cause such
diseases remain unclear, but it is believed that inappropriate induction of inflammatory responses is involved, triggered by
the innate immune system. As part of its mechanism of activation, the innate immune system employs germ-lined encoded
receptors, called pattern recognition receptors (PRRs) in order to ‘‘sense’’ pathogens. One such family of PRRs are the Toll
like receptor family (TLR). In the current study we aimed to elucidate the role of TLRs in Ureaplasma-induced inflammation in
human amniotic epithelial cells. Using silencing, as well as human embryonic kidney (HEK) transfected cell lines, we
demonstrate that TLR2, TLR6 and TLR9 are involved in the inflammatory responses against Ureaplasma parvum and
urealyticum serovars. Ureaplasma lipoproteins, such as Multiple Banded antigen (MBA), trigger responses via TLR2/TLR6,
whereas the whole bacterium is required for TLR9 activation. No major differences were observed between the different
serovars. Cell activation by Ureaplasma parvum and urealyticum seem to require lipid raft function and formation of
heterotypic receptor complexes comprising of TLR2 and TLR6 on the cell surface and TLR9 intracellularly.
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Introduction
Intrauterine infection is a major cause of spontaneous preterm
birth (PTB). The association of PTB and colonisation of the
cervicovaginal tract with specific microorganisms, especially before
32 wk of pregnancy, has long been recognised.
There is accumulating epidemiologic and experimental evi-
dence that intrauterine or postnatal infection with Ureaplasma
species is a significant risk factor for adverse pregnancy outcomes
and complications of extreme preterm birth such as bronchopul-
monary dysplasia and intraventricular hemorrhage [1]. Ureaplasma
are wall-less bacteria belonging to the Mycoplasmataceae. Intraam-
niotic infection with Ureaplasma species has serious complications
both for mothers as well as neonates. For the mother, Ureaplasma
infection is a major risk factor for spontaneous premature rupture
of membranes (PROM), clinical chorioamnionitis and preterm
delivery [2;3]. At least 40% of all preterm births are thought to
occur in mothers with Ureaplasma infection that is usually chronic,
subclinical and asymptomatic up to the time labour begins or the
membranes rupture. For the fetus or neonate, infections with
Ureaplasma are associated with a number of adverse outcomes,
including chronic lung disease, pneumonias, cerebral white matter
lesions, cerebral palsy and even death [4;5]. The mechanisms by
which Ureaplasmas cause such diseases remain unclear, but it is
believed that inappropriate induction of inflammatory responses is
involved, most likely triggered by the innate immune system [6;7].
It is believed that the innate immune response to these bacteria
can lead to the activation of pattern recognition receptors (PRRs),
production and release of pro-inflammatory mediators leading to
the complications associated with preterm and term infants.
Increased levels of pro-inflammatory mediators such as interleu-
kin-6 (IL-6), tumour-necrosis-factor (TNF-a), IL-1band IL-8 have
been shown in amniotic fluid infected with Ureaplasma, supporting
this hypothesis [8].
As part of its mechanism of activation, the innate immune
system employs germ-lined encoded receptors, called pattern
recognition receptors (PRRs) in order to ‘‘sense’’ pathogens. One
such family of PRRs are the Toll like receptor family (TLR), which
has been implicated in bacterial recognition.
The question that remains is which PRRs sense these bacteria,
especially since they are wall-less. Very little is known about the
innate immune recognition of Ureaplasma. There is a single study
that implicates TLR1, TLR2 and TLR6 in Ureaplasma parvum
innate-immune recognition [9], but this study was performed with
U. parvum serovar 3 (SV3), which was cultured in broths enriched
with yeast extract, thus results obtained for the activation of
certain TLRs might be attributed to the contaminating yeast
components.
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In this study we aimed to elucidate the role of TLRs in
Ureaplasma-induced inflammation. Previously we have shown that
U. parvum serovar 3 (SV3) was highly sensitive to bactericidal
effects of non-immune human serum, while SV14 showed
bactericidal resistance to serum from human serum containing
high titres of anti-Ureaplasma antibodies [10]. Therefore, in this
study we set out to compare the relative stimulation of TLRs by
these two isolates, which are closely related, yet separate species of
Ureaplasma.
Materials and Methods
Cells
HEK293 cells transfected with either TLR2, TLR2/TLR6 or
TLR4 were kindly provided by Professor Douglas Golenbock
(University of Massachusetts Medical School, Worcester, USA).
HEK293 cells transfected with either TLR7 or TLR9 were
obtained from Invivogen (USA).
Transfected cell lines were maintained in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal calf serum, 0.5
units/ml penicillin, 0.5 mg/ml streptomycin, 400 mg/ml G418 and
10 mg/ml Ciprofloxacin for HEK/TLR2, HEK/TLR2/TLR6,
and HEK/TLR4 and 10 mg/ml blasticidin for HEK/TLR7, and
HEK/TLR9.
Primary human amniotic epithelial cells were purchased from
TCS Cells Works (Buckingham, UK). The cells are isolated
according to referenced procedures. Human amniotic epithelial
cells are isolated from human amniotic membranes. Each isolate
undergoes extensive testing for the presence of specific amniotic
epithelial cell markers.
Ureaplasma parvum & urealyticum
Ureaplasma parvum SV3 (HPA5) and SV14 (HPA32) are clinical
isolates that have previously been characterised for susceptibility to
bactericidal serum activity [10], as well as Ureaplasma urealyticum
SV2 (Cook strain) which was obtained from the American Type
culture collection (ATCC). Ureaplasma were sub-cultured in
Ureaplasma selective medium obtained from Mycoplasma Expe-
rience (Surrey, U.K.). Strains were propagated in complete
medium as well as medium lacking yeast and all data were
compared to determine if propagation in the presence of yeast
altered the results. Ureaplasma yields were not adversely affected by
the absence of yeast in the culture medium and data presented
exclude any confounding effects of yeast proteins.
20 ml of bacteria were harvested by centrifugation 12,000 rpm
for 20 min. The pellet was washed three times in PBS and
resuspended in 500 ml of PBS. The cell number was determined by
absorbance (A60060.1 = 10
8 bacteria/ml. For stimulation we used
16108 bacteria/ml to 16107 cells/ml.
Materials
All chemicals were obtained from Sigma (Dorset, UK). TLR1,
TLR2, TLR4, TLR6, TLR7, and TLR9 specific polyclonal
antibodies were obtained from Santa Cruz Biotechnology Inc.
(Heidelberg, Germany). Recombinant Multiple Banded Antigen of
Ureaplasma (MBA) was obtained from Genway Biotech Inc (San
Diego, USA). The recombinant MBA was passed through a Profos
EndotrapH blue 10 column obtained from Hyglos (Munich,
Germany) in order to ensure there was no LPS. Different
concentrations were tested for IL-6 secretion and optimum results
were obtained with 1 mg/ml, thus this concentration was used for
all subsequent activation assays.
Flow cytometric determination of TLR expression
In order to investigate TLR expression before and after
Ureaplasma infection, human amniotic epithelial cells were either
stimulated with Ureaplasma serovars for 1 h or not, prior to fixation
with 4% paraformaldehyde. The cells were subsequently washed
and permeabilised using PBS/0.02%BSA/0.02% Saponin. After
permeabilisation, the cells were incubated with antibodies against
different TLRs and the appropriate secondary antibodies conju-
gated to FITC. The cells were washed twice in PBS/0.02% BSA/
0.02% Saponin and resuspended in 500 ml of PBS. Fluorescence
was detected using a FACSCalibur counting 10,000 cells not
gated.
Cytokine assays
Human amniotic epithelial cells were either not stimulated or
stimulated with Ureaplasma SV3, SV14 or SV2 (16108 bacteria/ml
to 16107 cells/ml) or MBA (1 mg/ml). The cultures were
incubated for the designated times. The supernatants were
collected and frozen until the cytokine assays were performed.
The BectonDickinson Human Inflammation cytometric bead
array system (Oxford, UK) was used in order to determine the
level of multiple cytokines at the same time.
RNA interference
RNA interference was used in order to silence the TLR2,
TLR4, TLR6, TLR7 and TLR9 genes. psiRNA clones were
obtained from InvivoGen (San Diego, USA). Human primary
amniotic epithelial cells (16105) were seeded in six well plates and
transfected with 0.5 mg of psiRNA using Lipofectamine 2000
(Invitrogen, Paisley, UK). After 48 h the level of silencing was
determined and cells were used for activation assays.
Cell labelling for FRET
Human amniotic epithelial cells were labelled with 100 ml of a
mixture of donor conjugated antibody Cy3 and acceptor
conjugated antibody Cy5. The cells were either not stimulated,
or stimulated with Ureaplasma parvum, urealyticum or MBA for
1 h, and were rinsed twice in PBS/0.02% BSA, prior to fixation
with 4% formaldehyde for 15 min. The cells were fixed in order to
prevent potential re-organisation of the proteins during the course
of the experiment.
Cells were imaged on a Carl Zeiss, Inc. LSM510 META
confocal microscope (with an Axiovert 200 fluorescent microscope)
using a 1.4 NA 636 Zeiss objective. The images were analysed
using LSM 2.5 image analysis software (Carl Zeiss, Inc.). Cy3 and
Cy5 were detected using the appropriate filter sets. Using typical
exposure times for image acquisition (less than 5 s), no fluores-
cence was observed from a Cy3-labelled specimen using the Cy5
filters, nor was Cy5 fluorescence detected using the Cy3 filter sets.
FRET measurements
FRET is a non-invasive imaging technique that can be used in
order to study molecular associations. It involves non-radiative
transfer of energy from the excited state of a donor molecule to an
appropriate acceptor. The rate of energy transfer is inversely
proportional to the sixth power of the distance, between donor and
acceptor. In the present study, FRET was measured using a
method as previously described.[11], [12], [13].
Confocal microscopy
Human amniotic epithelial cells on microchamber culture slides
(Lab-tek, Gibco), were stimulated with Ureaplasma SV3 or MBA
(1 mg/ml) for different time points, and were subsequently rinsed
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twice in PBS/0.02% BSA, prior to fixation with 4% formaldehyde
for 15 min. The cells were fixed in order to prevent potential re-
organisation of the proteins during the course of the experiment.
Cells were permeabilised using PBS/0.02% BSA/0.02% Saponin
and labelled with anti-TLR9, or MyD88 antibody followed by
incubation with the appropriate fluorescently-labelled secondary
antibody. Cells were imaged on a Carl Zeiss, Inc. LSM510 META
confocal microscope (with an Axiovert 200 fluorescent microscope)
using a 1.4 NA 636Zeiss objective.
Results
U. parvum SV3, SV14 and U. urealyticum SV2 activation of
human amniotic epithelial cells
Human amniotic epithelial cells represent the first line of
defense against intra-amniotic infection and thus provide a cell
barrier that should be able to recognise and respond the bacteria,
such as Ureaplasma. A probable result of their embryonic origin,
they have been shown to lack major histocompatibility complex
antigens but it has recently been shown that they express functional
TLRs [14]. Thus initially we investigated whether Ureaplasma
serovars could induce the production of pro-inflammatory cytokines
from human amniotic epithelial cells.
Human amniotic epithelial cells were incubated with Ureaplasma
SV2, SV3, and SV14 for different time points and the
supernatants were assayed for inflammatory cytokines. It was
shown that Ureaplasma serovars can induce TNF-a, IL-6, IL-1b
and IL-8 in human amniotic epithelial cells (Figure 1). Innate
immune reponses constitute the first line of host defence, thus pro-
inflammatory cytokines were found to be triggered rather quickly
and peaked within the first two hours. Therefore, it was decided to
stimulate the cells for 2 h for all subsequent stimulations.
TLR expression on human amniotic epithelial cells
Several TLRs have been implicated in the innate recognition of
bacteria. Since Ureaplasma are wall-less bacteria it is very
interesting to identify which TLRs are able to sense it, thus we
investigated the total TLR expression on human amniotic
epithelial cells before and after stimulation by Ureaplasma.
We found that human amniotic epithelial cells expressed
minimal levels of all TLRs that we tested (TLR1-9) prior to
Ureaplasma stimulation (Figure 2A). Interestingly, it was shown that
the expression of TLR2, TLR6 and most significantly TLR9
increased upon stimulation with Ureaplasma serovars (Figure 2A).
In order to investigate whether the effects observed are due to
the recognition of lipoproteins from Ureaplasma as it has previously
been suggested [9], we proceeded to stimulate human amniotic
epithelial cells with Multiple Banded Antigen (MBA). The MBA is
a surface exposed lipoprotein, which can undergo size and phase
variation in vitro and in vivo [15;16]. The MBA is predicted to be a
major ureaplasmal virulence factor and is the predominant antigen
recognised by sera during infections in humans [17]. MBA was
found to increase the expression of TLR2 and TLR6, but not
TLR9 in human amniotic epithelial cells (Figure 2A).
Ureaplasma-induced activation is mainly TLR2/6–
dependent on the cell surface
In order to investigate which TLRs might play a role in
Ureaplasma-induced activation we utilised transfected cell lines.
Human embryonic kidney (HEK) cells transfected with either
TLR1, TLR2, TLR2/TLR6, TLR4/MD2, TLR7 or TLR9 were
utilised. Untransfected HEK cells, which do not express TLRs, did
not produce IL-6 in response to Ureaplasma species (Figure 2B).
Similarly Ureaplasma did not trigger cytokine production in HEK
cells transfected with TLR7. HEK-TLR4 cells were shown to
produce a very small amount of IL-6 in response to Ureaplasma
serovars, but not in response to MBA (Figure 2B), suggesting that
TLR4 does not recognise MBA, but rather some other antigen. On
the contrary, HEK cells transfected with either TLR2, TLR2/6 or
TLR9 produced significant levels of IL-6 after incubation with
Ureaplasma serovars. MBA was able to trigger responses only in
TLR2 and TLR2/6 expressing cells, suggesting that TLR2/6
heterodimers must recognise these lipoproteins on the cell surface.
Interestingly HEK cells transfected with TLR9 had the highest IL-6
response against Ureaplasma species (Figure 2B), thus suggesting that
Ureaplasma-induced activation is mediated mainly through TLR2/6
on the cell surface and TLR9 intracellularly. Control cultures were
stimulated with known TLR2, TLR4, TLR7 or TLR9 ligands. It
was shown that Ureaplasma species were able to stimulate much
weaker immune responses compared to other TLR ligands, such as
LPS, LTA, ssRNA or CpGDNA.
Inhibition of Ureaplasma-induced activation of human
amniotic epithelial cells by silencing TLR2, TLR6 and TLR9
and to a lesser extent TLR4
In order to determine the role of TLR2/6 and TLR9 in
Ureaplasma recognition, we used RNA interference (siRNA) to
knock down the expression of TLR1, TLR2, TLR4, TLR6 and
TLR9 in primary human amniotic epithelial cells. Transfection
with synthetic TLR specific psiRNA resulted in approximately
70% decrease in TLR1, TLR2, TLR4, TLR6 and TLR9
expression as determined by western blotting (Figure 3A). Control
transfections of human amniotic epithelial cells with the psiRNA
vector did not affect TLR expression.
Following RNA interference, human amniotic epithelial cells
were incubated with Ureaplasma SV3, SV14, SV2 as well as MBA
(Figure 3B). Cytokine assays were performed after the designated
incubation times. It was shown that silencing of TLR2 inhibited
Ureaplasma- and MBA-induced cellular activation (Figure 3B), thus
suggesting the importance of TLR2 in Ureaplasma-mediated
Figure 1. Ureaplasma activation of human amniotic epithelial
cells. Human amniotic epithelial cells were incubated with Ureaplasma
(16108 bacteria/ml to 16107 cells/ml) parvum SV3 (black barcharts), U.
parvum SV14 (white barcharts) or U. urealyticum SV2 (grey bar charts)
for 2 h. The supernatants were harvested and assayed for cytokine
contents using the Cytometric Bead Array (CBA) system (Becton
Dickinson). Fluorescence was detected using a FACSCalibur (Becton-
Dickinson). The data represents the mean 6 SD of three independent
experiments.
doi:10.1371/journal.pone.0061199.g001
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activation of human amniotic epithelial cells. Although silencing of
TLR6 also inhibited Ureaplasma-and MBA-induced cellular acti-
vation, it was to a lesser extent, thus suggesting that innate
immune responses against Ureaplasma on the cell surface are
triggered mainly through TLR2. Interestingly, silencing of TLR9
did not inhibit MBA-induced activation, but only Ureaplasma-
induced cytokine response, to a level similar to that of TLR2, thus
Figure 2. TLR2/6 and TLR9-dependent cytokine secretion in response to Ureaplasma serovars. Human amniotic epithelial cells (A, B)
were either not stimulated (white bar charts) or stimulated with Ureaplasma serovars for 2 hours. The cells were fixed and permeabilised, followed by
antibody staining against the particular TLR molecule, and incubation with the appropriate secondary antibody conjugated to FITC. Fluorescence was
detected using a FACSCalibur (BectonDickinson The data presented is the mean of three independent experiments. HEK-293 cells (B) transfected with
TLR1, TLR2, TLR2/6, TLR4, TLR7 and TLR9 were either not incubated (white bar charts) or incubated with with Ureaplasma (16108 bacteria/ml to
16107 cells/ml) parvum SV3 (black barcharts), U. parvum SV14 (grey barcharts), U. urealyticum SV2 (stripped bar charts), or MBA (1 mg/ml) for 2 h.
Control cultures were stimulated with known TLR2, TLR4, TLR7 or TLR9 ligands. The supernatants were harvested and assayed for IL-6 content using
the Cytometric Bead Array (CBA) system (Becton Dickinson). Fluorescence was detected using a FACSCalibur (BectonDickinson). The data represents
the mean 6 SD of three independent experiments. Asterisks indicate statistically significant (p,0.05) increase in expression (A,B) or IL-6 secretion (C)
compared to corresponding unstimulated controls.
doi:10.1371/journal.pone.0061199.g002
TLR-Dependent Ureaplasma-Induced Inflammation
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suggesting that TLR9 is one of the main sensor for Ureaplasma
intracellularly.
Ureaplasma-induced receptor clusters on the cell surface
amniotic epithelial cells
In order to investigate whether Ureaplasma serovars could induce
the formation of receptor activation clusters on human amniotic
epithelial cells, we measured FRET in terms of dequenching of
donor fluorescence after complete photobleaching of the acceptor
fluorophore. We tested the energy transfer efficiency in our system
using a positive control, i.e. energy transfer between mAbs to
different epitopes on TLR4 molecules, showing that the maximum
energy transfer efficiency (E%) was 37 6 1.2. We proceeded to
measure FRET between TLR2 and different PRRs that we had
found to be implicated in Ureaplasma induced activation, TLR1,
TLR6, TLR4. Thus we measured FRET between TLR2 and
these molecules in response to the different Ureaplasma serovars as
well as MBA. TLR2 was found not to associate with these receptor
molecules prior to Ureaplasma stimulation (Figure 4A, white bars).
Energy transfer between TLR2-Cy3 and the various Cy5-
labelled PRRs was also measured. TLR2 was found not to
associate with TLR1, but to associate with TLR6, and to a much
lesser extent with TLR4 after Ureaplasma serovar stimulation.
Interestingly when cells were stimulated with MBA, there was
no association between TLR2 and TLR4.
In order to determine whether MBA directly interacts with
TLR2/6, we measured FRET between MBA-Cy3 and the various
Cy5-labelled PRRs (Figure 4B). It was shown that there was
energy transfer between MBA-Cy3 and TLR2 as well as TLR6,
Figure 3. Inhibition of Ureaplasma activation of human amniotic epithelial cells by silencing TLR2 and TLR9. TLR expression was
knocked down by siRNA and confirmed by western blotting (A). Following RNA interference, human amniotic epithelial cells were not stimulated
(white bar chasrts), or stimulated with Ureaplasma (16108 bacteria/ml to 16107 cells/ml) parvum SV3 (black barcharts), U. parvum SV14 (grey
barcharts), U. urealyticum SV2 (stripped bar charts) or MBA (1 mg/ml) for 2 h (B). The supernatants were harvested and assayed for cytokine secretion
using the Cytometric Bead Array (CBA) system (Becton Dickinson). Fluorescence was detected using a FACSCalibur (BectonDickinson). The data
represents the mean 6 SD of three independent experiments. Asterisks indicate statistically significant (p,0.05) decrease in IL-6 secretion compared
to corresponding unsilenced controls.
doi:10.1371/journal.pone.0061199.g003
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demonstrating that TLR2/6 heterodimers bind MBA and trigger
activation.
Control experiments using the method described by Kenworthy
et al.[12] ruled out the possibility that the FRET observed was due
to randomly distributed molecules (data not shown).
Recruitment of TLR2 in lipid rafts following Ureaplasma
stimulation on amniotic epithelial cells
It has been previously shown that regions of the plasma
membrane known as lipid rafts, or microdomains facilitate
bacterial LPS-induced cell activation [18;19]. In addition, we
have demonstrated that TLR2 is also recruited within lipid rafts
upon stimulation by its ligands [20]. Since we demonstrated that
Ureaplasma-induced cellular activation is mediated mainly through
TLR2 on the cell surface, we proceeded to determine whether
TLR2 was recruited within lipid rafts upon stimulation by
different Ureaplasma serovars or MBA. FRET experiments between
TLR2 and GM-1 ganglioside were performed before and after
stimulation by Ureaplasma serovars or MBA. TLR2 molecules were
labelled with Cy3-TLR2 and GM-1 ganglioside, a raft-associated
lipid, was labelled with Cy5-cholera toxin. It was shown that
similarly to TLR2 ligands, Ureaplasma and MBA stimulation could
recruit TLR2 in lipid rafts (Figure 5A).
Interestingly, TLR1 was found not to associate with GM1
ganglioside in response to Ureaplasma stimulation, thus suggesting
that TLR1 is not involved in the innate immune recognition of
Ureaplasma, whereas TLR6 was found to associate, leading us to
believe that TLR2 heterodimerises with TLR6 in order to
recognise Ureaplasma serovars.
In addition, although TLR4 has been shown to be recruited
within these microdomains after enterobacterial LPS stimulation
and this clustering is crucial for LPS-induced cytokine production
[18], in this study it was shown that there was minimal recruitment
of TLR4 within lipid raft compared to TLR2 in response to
Ureaplasma stimulation.
In order to test the significance of TLR-lipid raft recruitment in
response to Ureaplasma, we proceeded to disrupt lipid raft
formation using a lipid raft-disrupting drug, such as nystatin. It
was shown that when human amniotic epithelial cells were pre-
treated with nystatin (leading to lipid raft disruption), IL-6
responses were inhibited (Figure 5B), suggesting that accumulation
of TLR2 and TLR6 within lipid rafts in response to Ureaplasma is
crucial for signalling and pro-inflammatory cytokine responses.
Figure 4. TLR2 heterotypic associations in response to Ureaplasma. (A) Human amniotic epithelial cells were stimulated with no stimulus
(white bar charts), or incubated with Ureaplasma (16108 bacteria/ml to 16107 cells/ml) parvum SV3 (black barcharts), U. parvum SV14 (grey
barcharts), U. urealyticum SV2 (stripped bar charts) or MBA (1 mg/ml) for 1 h. Energy transfer between TLR2 (Cy3) and the different receptors was
measured from the increase in donor (Cy3) fluorescence after acceptor (Cy5) photobleaching. (B) Energy transfer between MBA (Cy3) and the
different receptors was measured from the increase in donor (Cy3) fluorescence after acceptor (Cy5) photobleaching. The percentage of energy
transfer and standard deviation was calculated from three independent experiments. Asterisks indicate statistically significant (p,0.05) increase in
energy transfer compared to corresponding unstimulated controls.
doi:10.1371/journal.pone.0061199.g004
TLR-Dependent Ureaplasma-Induced Inflammation
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Ureaplasma recognition intracellularly
In order to elucidate the intracellular interactions of Ureaplasma
with TLR9 we employed confocal microscopy. Amniotic epithelial
cells were stimulated with either Ureaplasma SV3 or MBA and in
order to determine whether signal transduction occurs through
TLR9 in the endosomes, we investigated the presence of MyD88,
which is an obligatory adaptor protein for TLR signal transduc-
tion by using anti MyD88-TRITC. Our results showed that
MyD88 is recruited in endosomes (Figure 6), where it colocalises
with TLR9 (Figure 6, middle row), when the cells are stimulated
with Ureaplasma. As expected, MBA stimulation did not recruit
MyD88 to the endosome (Figure 6, bottom row), thus demon-
strating that MBA is recognised on the cell surface, but once
Ureaplasma internalizes its DNA triggers TLR9 recognition
intracellularly.
Discussion
Intrauterine infection is a common cause of preterm delivery.
Chorioamniotitis or inflammation in the fetal membranes is
associated with over 60% of preterm deliveries [21]. The most
common organisms isolated from the amniotic fluid of women
with chorioamnionitis are the Ureaplasma species [22]. These
organisms are commonly found within the uterus in association
with spontaneous preterm labour and with preterm PROM. In
addition, the intrauterine presence of these organisms has been
linked with an increased production of a wide variety of cytokines,
matrix metalloproteinases and postaglandins, all believed to be in
Figure 5. TLR and GM-1 ganglioside FRET mearurements before and after Ureaplasma stimulation. TLR and GM-1 ganglioside FRET
mearurements before and after Ureaplasma stimulation of human amniotic epithelial cells (A). Energy transfer between Cy3-labelled TLR1, TLR2, TLR4
or TLR6 and GM-1 ganglioside (Cy5-cholera-toxin) before (white bar charts) and after stimulation with Ureaplasma (16108 bacteria/ml to 16107 cells/
ml) parvum SV3 (black barcharts), U.parvum SV14 (grey barcharts), U. urealyticum SV2 (stripped bar charts) or MBA (1 mg/ml). Energy transfer between
GM1 (Cy5) and the different receptors was measured from the increase in donor (Cy3) fluorescence after acceptor (Cy5) photobleaching. The
percentage of energy transfer and standard deviation was calculated from three independent experiments. Asterisks indicate statistically significant
(p,0.05) increase in energy transfer compared to corresponding unstimulated controls. (B) Inhibition of IL-6 production after lipid raft disruption.
Human amniotic epithelial cells were either not treated (white barcharts) or pre-treated with nystatin and subsequently stimulated with the different
Ureaplasma serovars or MBA. The supernatants were harvested and assayed for cytokine content using the Cytometric Bead Array (CBA) system
(Becton Dickinson). Fluorescence was detected using a FACSCalibur (BectonDickinson). The data represents the mean 6 SD of three independent
experiments. Asterisks indicate statistical significance (p,0.05).
doi:10.1371/journal.pone.0061199.g005
TLR-Dependent Ureaplasma-Induced Inflammation
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the causal pathway for PROM, thus activation of the innate
immune system has been suggested [8;23].
Ureaplasmas are unusual bacteria in that they have a plasma
membrane but lack a peptidoglycan cell wall, use urea as the sole
source of energy, and are dependent on the host for other
metabolic functions [24]. Since they lack a conventional bacterial
cell wall, the question that remains is how they trigger the innate
immune system and which PRRs they engage. It is imperative to
elucidate how Ureaplasma species can induce an inflammatory
response, if we are to understand how these bacteria cause
PROM.
Although much attention has been paid to TLR expression and
function in the female genital track [25;26], little is known about
TLRs in the human amniotic epithelial cells and how they
recognise Ureaplasma species. In this study, we set out to identify
which TLRs are involved in triggering pro-inflammatory respons-
es in response to Ureaplasma species in human amniotic epithelial
cells. Initially we investigated whether Ureaplasma can trigger the
secretion of pro-inflammatory cytokines in human amniotic
epithelial cells. Our experiments suggest that Ureaplasma SV2,
SV3 and SV14 are capable of inducing the secretion of pro-
inflammatory cytokines, which include TNF-..aIL-6, IL-8 and IL-
1b within the first two hours of their interaction with the host. No
significant difference was observed among the different Ureaplasma
serovars. Thus we proceeded to elucidate the mechanism by which
Ureaplasma can induce a cytokine response in human amniotic
epithelial cells. Since TLRs are the key receptors for sensing
bacteria, we investigated whether TLRs were involved in the
cytokine production in response to Ureaplasma. In order to examine
which if any, of the TLR molecules are involved, we utilised
HEK293 cells transfected with different TLRs. It was shown that
Ureaplasma species were able to activate only cells transfected with
either TLR2, TLR2/6 or TLR9 and to a lesser extent TLR4. This
is partly in agreement with Shimizu et al. [9] where they suggested
that TLR1, TLR2 and TLR6 are involved in sensing Ureaplasma
parvum. In our study, we did not find any TLR1 involvement,
whereas we found TLR9 involvement. Differences in the two
studies might lie in the fact that the Shimizu et al study was
performed with bacteria cultured in media supplemented with
yeast extract, which itself constitutes a PAMP, thus results
obtained might have been affected by the presence of yeast
components.
Furthermore, similarly with the study by Shimizu et al. [9] we
proceeded to investigate whether lipoproteins were triggering the
response observed. It was shown that MBA was triggering
responses via TLR2/6, thus suggesting that this heterodimer
might be engaged on the cell surface prior to Ureaplasma
internalization.
The ability to induce an inflammatory response via TLR9
seems to suggest that Ureaplasma species must internalise and
replicate within the host’s cells. Thus suggesting that the innate
recognition of Ureaplasma in the early stages of attachment to the
host cells is via the recognition of lipoproteins by TLR2/6, but
once the bacteria have infected the cells TLR9 is the main initiator
of the inflammatory response. This seems to be consistent with the
fact that TLR9 is only expressed intracellularly, and thus the
bacteria must internalise in order to interact with these receptors.
Interestingly, when we investigated whether Ureaplasma species
could induce the formation of receptor clusters on the cell surface
of human amniotic epithelial cells, it was shown that they could
induce receptor clusters comprising of TLR2/6 on the cell surface.
These clusters seem to form within lipid rafts. Since these
Figure 6. Ureaplasma internalization recruits MyD88 in endosomes. Human amniotic epithelial cells were either not stimulated (top panels)
or stimulated with either Ureaplasma SV3 (middle panels) or MBA (bottom panels) and imaged using a Zeiss 510 META confocal microscope.
Intracellular MyD88 was stained using a polyclonal antibody directly labelled with FITC. TLR9 were labelled using anti-TLR9-TRITC. TOPRO was used to
label the nucleus of the cells. Merged images showing extensive overlay of areas positive for MyD88 and TLR9 are seen as yellow (Scale Bar, 10 mm).
doi:10.1371/journal.pone.0061199.g006
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pathogens trigger responses via TLR2, it is possible that CD36
could act as a key molecule within the receptor cluster. CD36 has
recently been shown to associate with TLR2 [27] and this
interaction might exacerbate the inflammatory response.
Furthermore, when we investigated whether TLR9 was
triggering signalling from the endosomes in response to Ureaplasma
infection, it was shown that following Ureaplasma infection, TLR9
co-localised in the endosomes with the signalling adaptor molecule
MyD88. Therefore, our data suggests that Ureaplasma CpGDNA
must be targeted to endosomal compartments upon internalisa-
tion. TLR9 is perfectly placed in endosomal compartments in
order to be able to ‘‘sample’’ this endocytosed material and trigger
cytokine response whenever this molecular ‘‘signature’’ is recog-
nised.
Overall our data suggests that the inflammatory response
triggered by Ureaplasma in amniotic epithelial cells is mediated by
the synergic activation of multiple TLRs. It seems that a part of
the inflammatory response is triggered by lipoproteins, such as
MBA, in the initial stages of the bacterial attachment to the cell
surface and is mediated via TLR2. MBA is a surface exposed
lipoprotein, which can undergo size and phase variation in vitro
and in vivo. It has been previously shown that MBA size variation is
associated with the severity of chorioamnionitis in a pregnant
sheep model of intra-amniotic Ureaplasma infection [28], therefore
MBA size variation might influence the interaction of MBA with
TLR2/TLR6 heterodimers and thus determine the intensity of the
innate immune response and consequently the severity of amniotic
fluid infection. One effective microbial strategy for avoiding host
recognition is the modification/variation of PAMPs. Since our
study demonstrates that MBA is a PAMP, the primary function of
this antigenic variation could be to evade the innate immune
response, and thus MBA variation could influence the virulence of
the different strains. This might explain why certain Ureaplasma
isolates are more associated with severe disease than others.
Although, it has been previously suggested that in addition to
TLR2, TLR4 might be activated in response to Ureaplasma [29], in
our study we only observed TLR2 activation in response to all
Ureaplasma serovars tested. The fact that MBA engages TLR2, and
not TLR4, might shed more light into the reasons why these
organisms can develop chronic, low-level inflammation of
amniotic epithelial cells leading to PROM. Activation via TLR2
results in a subdued inflammatory response [30] allowing the
organism to establish a chronic foothold in amniotic epithelial
cells.
Synergic inflammatory response of TLR2, TLR6 and TLR9
seem to produce a chronic inflammatory response against
Ureaplasma, which could eventually lead to irreversible injury of
fetal membranes. There are several clinical implications of our
findings, since the current study is the first study into the
mechanisms by which Ureaplasma species cause chronic inflamma-
tion of the amniotic epithelium, and might help us find new TLR-
based therapeutic targets for Ureaplasma-induced chorioamniotitis.
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